Prof Abeer Shaaban is a Consultant Pathologist at Queen Elizabeth Hospital Birmingham and Professor of Cancer and Genomic Sciences, University of Birmingham, Uk. She is Professional Clinical Advisor (PCA) for the UK NHS Breast Screening Programme.
She published 225 peer reviewed publications in diagnostic and molecular pathology and digital pathology, several book chapters and contributed to a number of international guidelines including the WHO Blue Book for Genomic Syndromes, the WHO Blue Book for Breast tumours 2019 and 2025, the International Collaboration on Cancer Reporting (ICCR) DCIS dataset 2021, the RCPath Breast Pathology reporting guidelines and the European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO, Non operative UK Breast Reporting Guidelines, HER2 UK reporting Guidelines and HER2 international consensus. She is currently contributing to ABS guidance on male breast cancer and inflammatory breast cancer.